Vaxart to Host Second Quarter 2023 Business Update and Financial Results Conference Call on August 3
July 27 2023 - 8:00AM
Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a
business update and report financial results for the second quarter
ended June 30, 2023 after the market close on Thursday, August 3,
2023. The Vaxart senior management team will host a conference call
on the same day, beginning at 4:30 p.m. ET.
The conference call can be accessed using the
following information:
Webcast: Click hereDate: Thursday, August 3,
2023 – 4:30 p.m. ETDomestic: (877) 407-0832International: (201)
689-8433Conference ID: 13739413
Investors may submit written questions in
advance of the conference call to ir@vaxart.com.
A replay of the webcast will be available on the
Company’s website at www.vaxart.com following the conclusion of the
event.
About VaxartVaxart is a
clinical-stage biotechnology company developing a range of oral
recombinant vaccines based on its proprietary delivery platform.
Vaxart vaccines are designed to be administered using pills that
can be stored and shipped without refrigeration and eliminate the
risk of needle-stick injury. Vaxart believes that its proprietary
pill vaccine delivery platform is suitable to deliver recombinant
vaccines, positioning the company to develop oral versions of
currently marketed vaccines and to design recombinant vaccines for
new indications. Vaxart’s development programs currently include
pill vaccines designed to protect against norovirus, coronavirus,
seasonal influenza, and respiratory syncytial virus (RSV), as well
as a therapeutic vaccine for human papillomavirus (HPV), Vaxart’s
first immune-oncology indication. Vaxart has filed broad domestic
and international patent applications covering its proprietary
technology and creations for oral vaccination using adenovirus and
TLR3 agonists.
Contacts
Vaxart Media Relations: |
Investor Relations: |
Mark Herr |
Andrew Blazier |
Vaxart, Inc. |
FINN Partners |
mherr@vaxart.com |
IR@vaxart.com |
(203) 517-8957 |
(646) 871-8486 |
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Apr 2024 to May 2024
Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From May 2023 to May 2024